Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy.
作者信息
Malapelle Umberto, Leprieur Etienne Giroux, Kamga Paul Takam, Chiasseu Marius Tresor, Rolfo Christian
机构信息
Department of Public Health, University of Naples Federico II, Naples, Italy.
Department of Respiratory Diseases and Thoracic Oncology, APHP-Hopital Ambroise Pare, Boulogne-Billancourt, France.
出版信息
Front Oncol. 2021 May 14;11:694578. doi: 10.3389/fonc.2021.694578. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy.社论：非小细胞肺癌的新兴生物标志物：诊断与治疗的最新进展
Front Oncol. 2021 May 14;11:694578. doi: 10.3389/fonc.2021.694578. eCollection 2021.
2
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.将下一代测序（NGS）纳入亚洲非小细胞肺癌（NSCLC）人群的实用性：可操作改变的增量收益和成本效益分析。
Lung Cancer. 2020 Jan;139:207-215. doi: 10.1016/j.lungcan.2019.11.022. Epub 2019 Nov 26.
3
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.非小细胞肺癌患者 NGS 液体活检分析的临床可行性。
PLoS One. 2019 Dec 20;14(12):e0226853. doi: 10.1371/journal.pone.0226853. eCollection 2019.
4
Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.通过连续DNA和RNA测序优化非小细胞肺癌中的突变和融合检测
J Thorac Oncol. 2020 Jun;15(6):1000-1014. doi: 10.1016/j.jtho.2020.01.019. Epub 2020 Jan 31.
5
Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy.非小细胞肺癌的生物标志物：个体化靶向治疗的观点。
Anticancer Agents Med Chem. 2018;18(15):2070-2077. doi: 10.2174/1871520618666180827102101.
6
Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review.晚期非小细胞肺癌（NSCLC）免疫治疗反应和毒性的循环生物标志物：综述
Cancers (Basel). 2021 Apr 9;13(8):1794. doi: 10.3390/cancers13081794.
7
Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.循环长链非编码RNA在非小细胞肺癌中的诊断和预后潜力
Cell Physiol Biochem. 2018;49(2):816-827. doi: 10.1159/000493043. Epub 2018 Aug 30.
8
MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).基于 microRNA 的生物标志物用于诊断非小细胞肺癌（NSCLC）。
Thorac Cancer. 2020 Mar;11(3):762-768. doi: 10.1111/1759-7714.13337. Epub 2020 Jan 28.
9
The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis.用于非小细胞肺癌（NSCLC）诊断的血清生物标志物评估
Front Physiol. 2018 Nov 29;9:1710. doi: 10.3389/fphys.2018.01710. eCollection 2018.
10
Differentially expressed and activated proteins associated with non small cell lung cancer tissues.与非小细胞肺癌组织相关的差异表达和激活蛋白
Respir Res. 2015 Jun 24;16(1):74. doi: 10.1186/s12931-015-0234-2.
引用本文的文献
1
Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment.用于监测接受二线奥希替尼治疗的非小细胞肺癌患者的综合液体活检分析
Front Oncol. 2024 Oct 21;14:1435537. doi: 10.3389/fonc.2024.1435537. eCollection 2024.
2
Abnormalities in the KRAS Gene and Treatment Options for NSCLC Patients with the G12C Mutation in This Gene-A Literature Review and Single-Center Experience.KRAS基因异常与该基因G12C突变的非小细胞肺癌患者的治疗选择——文献综述与单中心经验
Biomedicines. 2024 Jan 31;12(2):325. doi: 10.3390/biomedicines12020325.
3
Deep Learning for Lung Cancer Diagnosis, Prognosis and Prediction Using Histological and Cytological Images: A Systematic Review.使用组织学和细胞学图像的深度学习在肺癌诊断、预后和预测中的应用：一项系统综述。
Cancers (Basel). 2023 Aug 5;15(15):3981. doi: 10.3390/cancers15153981.
4
CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.环状 RNA OXCT1 通过吸附 miR-516b-5p 和上调 SLC1A5 促进非小细胞肺癌的恶性进展和谷氨酰胺代谢。
Cell Cycle. 2023 May;22(10):1182-1195. doi: 10.1080/15384101.2022.2071565. Epub 2023 Mar 2.
5
"How Long Have I Got?" in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question.对于生存时间至少3个月至长达10年的IV期非小细胞肺癌患者，“我还能活多久？”这个问题，长期、中期和短期生存预测的准确性不足以回答。
Front Oncol. 2021 Dec 21;11:761042. doi: 10.3389/fonc.2021.761042. eCollection 2021.
6
High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors.循环中 Sonic Hedgehog 蛋白水平高与酪氨酸激酶抑制剂治疗的 EGFR 突变晚期非小细胞肺癌预后不良相关。
Front Oncol. 2021 Dec 14;11:747692. doi: 10.3389/fonc.2021.747692. eCollection 2021.
Zotero 插件